Efficacy and Safety of 400 μg Twice Daily of Aclidinium Bromide vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

August 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions

COPD

Interventions

DRUG

aclidinium bromide 400 μg

DRUG

aclidinium bromide placebo

Trial Locations (1)

Seoul National University Hospital, Seoul